Rapport Therapeutics

RAPP

Rapport Therapeutics has been a target of short sellers for a while. The current short interest of 6.36% is roughly at the average of the last 12 months (5.75%).

Short Interest Trend

Share Price

Total NSP

6.36%

-0.30%

vs. last month

Also interesting? All insider buys at Rapport Therapeutics

Found an error? Questions? Ideas?